American Journal of Respiratory and Critical Care Medicine

We have investigated the relationship between decline in lung function and dietary intakes of magnesium, vitamin C, and other antioxidant vitamins in a general population cohort in Nottingham, United Kingdom. In 1991, we measured dietary intake by semiquantitative food frequency questionnaire, forced expiratory volume in 1 second (FEV1), and respiratory symptoms in a cross-sectional survey of 2,633 adults aged 18–70. Nine years later we repeated these measures in 1,346 of these individuals. In cross-sectional analyses, after adjustment for smoking and other confounders, higher intakes of vitamin C and magnesium, but not vitamins A or E, were associated with higher levels of FEV1 in both 1991 and 2000. In longitudinal analysis with adjustment for confounders, decline in FEV1 between 1991 and 2000 was lower amongst those with higher average vitamin C intake by 50.8 ml (95% confidence interval, 3.8–97.9) per 100 mg of vitamin C per day, but was unrelated to magnesium intake. There was no relationship between decline in FEV1 and intake of vitamins A or E. This study suggests that a high dietary intake of vitamin C, or of foods rich in this vitamin, may reduce the rate of loss of lung function in adults and thereby help to prevent chronic obstructive pulmonary disease.

There is increasing evidence from epidemiologic studies that dietary factors, particularly antioxidant vitamins and minerals, may be involved in the etiology of chronic obstructive pulmonary disease and asthma (1). In particular, there is evidence that individuals with a high intake of vitamin C, A, and E tend to have higher levels of lung function (115), whereas a number of studies have now suggested an association between higher magnesium intake and both higher lung function and a reduced risk of asthma (1619). However, the majority of the evidence available to date has come from cross-sectional studies, and it is therefore unclear whether these associations represent causal and potentially modifiable effects on lung health, or whether they arise from the effects of unrecognized confounding. It is therefore important to explore the relationship between diet and lung function more extensively in longitudinal studies, of which only two have been reported to date (20, 21). We now report a longitudinal cohort study conducted in a population in which we have previously observed cross-sectional associations between forced expiratory volume in 1 second (FEV1) and intake of both vitamin C and magnesium (2, 16), exploring the relationship between intake of these nutrients and of vitamins A and E on decline in FEV1 and incidence of wheeze over a 9-year period.

Participants

In 1991, a systematic sample of 2,633 adults aged 18–70 living in Nottingham, UK participated in a cross-sectional study of the relationship between diet, asthma, and chronic obstructive pulmonary disease (2, 16, 22). Nine years later, we invited all surviving individuals to participate in a follow-up study. Nonresponders were sent two reminders by post and, where possible, contacted by telephone. The study was approved by the Nottingham City Hospital ethics committee.

Methods

Consenting participants completed an interviewer-administered, computerized semiquantitative food frequency questionnaire (Diet Q; Tinuviel Software, Warrington, Cheshire, UK), and a questionnaire on respiratory symptoms, smoking, and other variables, as in 1991 (2, 16). FEV1 and FVC were measured using a dry bellows spirometer (Vitalograph, Buckingham, UK), recording the best of three satisfactory attempts. Skin sensitivity to Dermatophagoides pternyssinus, grass pollen, cat dander, alternaria, cladosporium, histamine, and saline controls (Allergopharma, Reinbek, Germany) was assessed using standard skin-prick test methods, the wheal response to each allergen being measured as the average of two diameters at right angles to each other, one of which was the largest measurable diameter.

Analysis

Self-reported smoking history was used to classify participants as never-smokers, ex-smokers (those who had not smoked for at least one month before the appointment), and current smokers. Smoking data from 1991 were used to validate never-smoking status, by reclassifying self-reported non-smokers in 2000, classified as smokers or ex-smokers in 1991, as ex-smokers. Data on self-reported level of cigarette consumption were used to calculate pack-years. Atopy was defined as an allergen wheal response of 3 mm or greater than the saline control response to at least one of the allergens; because the allergen solutions used in the two studies were from different manufacturers we used only the 1991 data to define atopy in the longitudinal analysis. Socioeconomic status was determined using the Registrar General's classification (23). Wheeze status was determined by the response to the question “have you had wheezing or whistling in your chest at anytime in the last 12 months?” Nutrient intakes were adjusted for total energy intake by linear regression (24) and standardized to the nutrient level at the mean level of total energy intake. Predicted FEV1 values were modeled for each sex in nonsmoking, nonasthmatic, nonwheezing individuals with terms for age, height, age squared, and age–height interaction. Individual FEV1 values were expressed as the residual difference from the predicted value. We regressed FEV1 residuals cross-sectionally on adjusted nutrient intake in 1991 and 2000, and longitudinal change in FEV1 residuals on adjusted average nutrient intake between 1991 and 2000, and change in adjusted nutrient intake between 1991 and 2000. We augmented these models with potential confounders, including body mass index, smoking history, atopy, and social class, first individually and then in a multivariate model. We examined the shape of the relationship between FEV1 and nutrient intake by plotting deciles of nutrient intake and tested for linearity using the likelihood ratio test. Multiple logistic regression was used to estimate independent effects on the odds of wheeze in 2000 and on the incidence of wheeze between 1991 and 2000. All analyses were performed in STATA version 7 (Stata Corporation, College Station, TX) and were repeated after excluding participants using vitamin supplements.

Using a conservative estimate of 250 ml for the within-subject standard deviation for change in FEV1 over 9 years, the a sample size of 1,343 individuals provides 90% power to detect a difference in change in FEV1 of 90 ml between the lowest and highest deciles of any nutrient during this period.

Of the original sample of 2,633 individuals, 1,346 (51%) participated in the present study; a further 4% of the original population had died, 7% had moved from Nottingham, 23% declined or were unable to participate, and we were unable to establish contact with 15%. Three participants could not provide satisfactory lung function measure and were excluded from further analyses. The mean (± SD) age of the 1,343 participants analyzed was 56.1 (12.4) years, range 27–80; 51% were never-smokers, 38% ex-smokers, and 12% current smokers; 69% were atopic (seven people were unable to provide valid skin-prick results); and 25% reported wheezing in the past 12 months. Participation in 2000 was lower in the younger age groups, but in other respects the aforementioned characteristics of participants in 2000 were similar to those of the original 1991 study population (Table 1)

TABLE 1. Demographic details and reported wheeze and asthma status in 1991 in the original study population and those participating in the 2000 study



Participants in
1991 (n = 2,633)
2000 (n = 1,343)

n
%
n
%
Sex
Male1,31249.866649.6
Female1,32150.267750.4
Age
18–2942616.213710.2
30–3956221.326519.7
40–4967326.637628.0
50–5952620.034225.5
60–7044616.922316.6
Smoking status
Never1,30649.671353.1
Ex73027.739029.0
Current59722.724017.9
Atopy
No1,83269.693369.5
Yes80130.441030.5
Wheezing in the past
     12 months
No2,00176.01,06679.4
Yes63224.027720.6
Self-reported doctor
     diagnosed asthma
No2,39791.01,24092.3
Yes
236
9.0
103
7.7
. Mean FEV1 (± SD) in 1991 in participants in the present study was 3.18 (0.84) L, and in nonparticipants 3.19 (0.99) L. Mean FEV1 declined in participants to 2.84 (0.85) L, equivalent to a mean decline of 37.8 (0.03) ml/year. Decline in FEV1 was higher in males, smokers, and older participants, but was not related to atopy (Table 2)

TABLE 2. Change in lung function over the 9 years by age categories, smoking history, and atopy




FEV1 Total
 Decline in
 Milliliters

SD

FEV1 Decline
 in Milliliters
 per Year

SD
Sex
Male384.8325.142.836.1
Female297.2245.333.027.3
Age group in 2000
28–39241.4292.426.832.5
40–49294.4243.832.727.1
50–59343.9263.038.229.2
60–69378.4300.942.033.4
70–80409.5348.545.538.7
Smoking status in 2000
Never311.1282.634.631.4
Ex358.4308.639.834.3
Current411.7248.445.727.6
Atopy in 1991
No341.3286.037.931.8
Yes
339.1
302.1
37.7
33.6
.

Mean vitamin C intake (± SD) increased significantly from 101.5 (39.9) mg/day in 1991 to 123.7 (50.9) mg/day in 2000, and magnesium intake decreased significantly from 384.5 (110.2) mg/day in 1991 to 329.5 (78.7) mg/day in 2000. The fall in magnesium intake was greater in men (86.2 [112.3] mg/day) than in women (24.0 [87.8] mg/day) and the increase in vitamin C smaller in men (18.4 [44.2] mg/day) than in women (25.8 [50.9] mg/day). Energy-adjusted intakes of these nutrients exhibited similar changes. Average total energy intake in our study population fell slightly over the 9 years from 2,091.0 (565.2) to 1,947.5 (470.4) kcal/day.

Cross-sectional Results

There were positive associations between FEV1 and both vitamin C and magnesium intake in the 2000 survey (Table 3)

TABLE 3. Cross-sectional associations between fev1 residuals and the energy-adjusted intake of vitamin c and magnesium in 2000




Vitamin C 2000

Magnesium 2000
Potential Confounders Included in the Model
Main Effect per 100 mg
95% CI
Mean Effect per 100 mg
95% CI
Unadjusted117.762.2–173.299.455.7–143.0
Adjusted for
Smoking history and pack years76.4 22.4–130.359.216.5–101.8
BMI118.3 62.8–173.798.645.9–142.2
Atopy117.3 61.8–172.999.856.1–143.4
Social class103.1 47.1–159.085.941.5–130.2
Fully adjusted66.8 12.2–121.452.99.6–96.2
Fully adjusted and mutually adjusted*
43.6
−16.6–103.7
37.1
−10.6–84.7

* Vitamin C and magnesium both in the model.

Definition of abbreviations: BMI = body mass index; CI = confidence interval; FEV1 = forced expiratory volume in 1 second.

, and no significant evidence that the relationship was not linear (likelihood ratio test p = 0.92 for vitamin C, p = 0.09 for magnesium). The regression coefficients were unaffected by adjustment for body mass index or atopy, and reduced by adjustment for smoking and social class. The effects of vitamin C and magnesium on FEV1 remained significant after adjustment for these potential confounders, such that a 100 mg/day higher intake of vitamin C and magnesium, respectively, were associated with a 66.8 (95% confidence interval [CI], 12.2–121.4) ml and 52.9 (95% CI, 9.6–96.2) ml higher FEV1. Restriction of the analysis to participants who were not using vitamin or mineral supplements in 2000 marginally increased the magnitude of these estimates (78.8 [95% CI, 17.4–139.9] ml and 61.9 [95% CI, 14.2–109.7] ml, respectively). The shape of the relationships between vitamin C and magnesium intake in deciles and FEV1 residuals in 1991 and 2000 are shown in Figures 1 and 2 . The effects of these nutrients in 2000 were reduced and were not independently significant when mutually adjusted (Table 3), probably because vitamin C and magnesium intake were significantly correlated (r = 0.44). Vitamin E was associated positively with FEV1 in univariate analysis, but was not independently significant after adjusting for smoking history. There was no relationship between lung function and vitamin A intake, and examining these relationships nutrients intakes without adjustment for energy intake did not appreciably change the magnitude or significance of the observed effects.

There was also a cross-sectional univariate relationship between magnesium intake and current wheeze in 2000, the odds ratio for the highest compared with the lowest quintile of magnesium being 0.67 (95% CI, 0.45–1.00). However, this effect was not independently significant after adjusting for potential confounders (odds ratio, 0.84; 95% CI, 0.55–1.28). Wheezing was not associated with vitamin C, A, or E intake, either before or after adjustment for confounders. There was no relationship between any of these nutrient intakes and atopy, and no evidence of interaction between any nutrient effect and age, atopy, or smoking history.

Longitudinal Results

Change in lung function between 1991 and 2000 was significantly associated with average vitamin C intake between 1991 and 2000, such that after adjusting for smoking and social class, a 100 mg higher average intake of vitamin C was related to a 50.8 (95% CI, 3.8–97.9) ml smaller reduction in FEV1 (Table 4

TABLE 4. Longitudinal associations between change in fev1 residuals and energy-adjusted average vitamin c intake



Average Vitamin C

Main Effect
 per 100 mg*
95% CI
Unadjusted60.014.2–105.9
Adjusted for
Smoking history and pack years50.03.7–96.3
BMI60.014.2–106.0
Atopy57.911.9–104.0
Social class62.115.7–108.6
All the above factors
50.8
3.8–97.9

* Mean effect of change in FEV1 in milliliters over the 9 years.

For definition of abbreviations see Table 3.

and Figure 3) , equivalent to 5.6 (95% CI, 0.4–10.8) ml per year. This relationship was slightly stronger among participants not using vitamin supplements. Adjustment for change in body mass index, change in smoking status over the 9 years, or age did not affect these results. There was no evidence of interaction with smoking status, age, or atopy. There was no significant relationship between average magnesium intake and decline in FEV1, no relationship between change in vitamin C or magnesium intake and change in lung function either before or after adjustment for confounders, and no association between either of these nutrient intakes and the incidence of wheezing. Similar analyses of the relationship between vitamin E and A and all of the aforesaid outcomes revealed no significant associations.

In this study, we have confirmed that a cross-sectional relationship between vitamin C and magnesium intake and lung function, as previously reported in our population-based sample of adults (2, 16), was still present in cross-sectional analysis at a 9-year follow-up. We have also demonstrated for the first time in adults that higher amounts of vitamin C intake are associated with a lower rate of decline in FEV1. We found no evidence of an association between longitudinal decline in FEV1 and intake of magnesium, vitamin E, or vitamin A. In contrast to a previous longitudinal study for vitamin intake and asthma incidence (25), we found no relationship longitudinally or cross-sectionally between wheezing in the past year and any of these nutrient intakes. However, our sample size was substantially smaller than in the previous report (25), so the absence of a relationship in our study could be due to lower statistical power.

Our original study population was randomly selected from the electoral register of a Local Authority Area of Nottingham and is therefore likely to be a representative sample of the general population. Although participation in the present study was potentially biased by survival, nonmigration, and motivation to participate, our data suggest that the participants in 2000 were in fact broadly similar to the original population in terms of diet, smoking history, initial lung function, and history of respiratory disease. Participation in 2000 was lower in the younger age groups from the 1991 sample, but there are no a priori grounds to suspect that this will appreciably bias the relationship between nutrient intakes and lung function in either the cross-sectional or longitudinal analyses. A slightly lower percentage of smokers participated in the follow-up visit, though this it is unlikely to have had a major effect on our results because we adjusted for smoking in the analysis and found no interaction of any effect with smoking history. We adjusted nutrient values for total energy intake to control for any potential confounding by total energy intake and used an average of the 1991 and 2000 nutrient intakes as the more representative marker of average nutrient intake over the 9 years as in previous studies (20, 21, 26). The distribution of amounts of vitamin C and magnesium were slightly skewed to the right but any departure from normality was minor and not improved by log transformation. For simplicity, we therefore analyzed the untransformed nutrient values. We modeled change in FEV1 using change in residuals; although we also explored the effect of modeling absolute change in FEV1 over time with adjustment for confounding factors, both methods produced similar results, so we have used the former approach in the presentation of this paper.

In the 1991 survey, we found a strong association between magnesium and lung function and airway hyperresponsiveness, and several subsequent studies (1719, 27), though not all (21) have since provided further evidence in support of these observations. Cross-sectionally in 2000, we again found a positive association between level of magnesium intake and lung function, though this effect appears to have applied predominantly with the lower deciles of intake (Figure 2). However, the absence of a longitudinal relationship in the present study argues against this nutrient having a major influence on decline in lung function in adult life, though it remains possible that magnesium may be important in the early development of lung function, given the previously reported strong association between magnesium intake and asthma or wheeze in a study in children (17). We did not measure airway hyperresponsiveness in the present study and are therefore unable to comment on the effect of magnesium intake in relation to this outcome in 2000.

Vitamin C has previously been linked with higher lung function in several studies using different measures of intake, including dietary recall (57, 9) and plasma vitamin C concentrations (3, 4, 8). Fresh fruit intake has also been associated with higher lung function (20, 28), and although vitamin C may play an important role in the association, other nutrients in fresh fruit may also be involved. Our cross-sectional results are consistent with these previous findings, though in contrast to previous studies, we did not find any evidence on this occasion that this effect may be stronger in smokers than in nonsmokers (2, 4). Our longitudinal analysis also provided evidence, for the first time, that higher average amounts of vitamin C intake were associated with a decrease in the decline of FEV1 over a prospective 9-year time period.

To our knowledge, only two other studies have examined the effect of diet on lung function (as opposed to respiratory symptoms) in a longitudinal design. The first of these demonstrated that a reduction in fresh fruit consumption in adults was related to a greater decline in FEV1 over a 7-year period, but that average fruit consumption was not related to the rate of decline (20). From this the authors hypothesized that rate of decline of lung function represented a potentially reversible effect. This study did not include detailed dietary data and was therefore not able to look at individual nutrient effects. In contrast, Butland and coworkers demonstrated that higher average apple consumption was associated with a smaller decline in lung function in adult men, but found no significant evidence of an effect of individual nutrients and no relationship between change in fruit consumption or nutrient intake and change in FEV1 (21). Our observation of an effect of average vitamin C intake on FEV1 is broadly consistent with these findings, but in our case, the absence of a relation between change in nutrient intake and decline in FEV1 argues against an acutely reversible effect. Our data also suggest that the protective effect of vitamin C applies particularly to those in the lower range of intake (below 90 mg/day, see Figure 3). In addition, there is one study that randomized 12 smokers with chronic obstructive pulmonary disease for a month to take vitamin A or a placebo and found an improvement in FEV1 in those subjects receiving the vitamin A supplements (29). These results are not in contrast with our results, as the majority of our population vitamin A intake reduced over the 9 years.

The relationship between atopy and diet is not clearly understood. We have previously reported a relationship between concentrations of vitamin E and both allergen skin sensitization and IgE concentrations, more strongly in relation to IgE concentrations (30), and evidence consistent with the observation has been reported from the European Respiratory Health Survey (31). Cross-sectionally in 2000, we found no relationship between vitamin E and allergen skin sensitization, but we do not have serum IgE data in the present study. However, we found no evidence that atopy was a major determinant of decline in FEV1.

Overall our findings lend additional support to the hypothesis that a diet rich in the foods that provide vitamin C is likely to be beneficial for lung health, and by reducing the size of decline of lung function over time, are likely to reduce the risk of chronic obstructive pulmonary disease. It is important to examine how early in life the benefits of vitamin C or relevant foods operate and to determine more precisely which nutrients or food groups are likely to be involved, to guide the development of intervention studies and establish whether decline in lung function can be reduced through dietary change.

The authors thank Marie Cooper for organizing the participants for the follow-up visits, the field workers for their assistance in collecting the data, the General Practitioners and their colleagues for allowing us to use their facilities, and the people of Gedling who agreed to take part.

1. Fogarty A, Britton J. The role of diet in the aetiology of asthma. Clin Exp Allergy 2000;30:615–627.
2. Britton JR, Pavord ID, Richards KA, Knox AJ, Wisniewski AF, Lewis SA, Tattersfield AE, Weiss ST. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995;151:1383–1387.
3. Schunemann HJ, Grant BJ, Freudenheim JL, Muti P, Browne RW, Drake JA, Klocke RA, Trevisan M. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med 2001;163:1246–1255.
4. Sargeant LA, Jaeckel A, Wareham NJ. Interaction of vitamin C with the relation between smoking and obstructive airways disease in EPIC Norfolk: European prospective investigation into cancer and nutrition. Eur Respir J 2000;16:397–403.
5. Tabak C, Smit HA, Rasanen L, Fidanza F, Menotti A, Nissinen A, Feskens EJM, Heederik D, Kromhout D. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Thorax 1999;54:1021–1026.
6. Hu GZ, Zhang X, Chen JS, Peto R, Campbell TC, Cassano PA. Dietary vitamin C intake and lung function in rural China. Am J Epidemiol 1998;148:594–599.
7. Grievink L, Smit HA, Ocke MC, van't Veer P, Kromhout D. Dietary intake of antioxidant (pro) vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax 1998;53:166–171.
8. Ness AR, Khaw KT, Bingham S, Day DE. Vitamin C status and respiratory function. Eur J Clin Nutr 1996;50:573–579.
9. Schwartz J, Weiss ST. The relationship between dietary vitamin C intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Am J Clin Nutr 1994;59:110–114.
10. Grievink L, de Waart FG, Schouten EG, Kok FJ. Serum carotenoids, alpha-tocopherol, and lung function among Dutch elderly. Am J Respir Crit Care Med 2000;161(3 Pt 1):790–795.
11. Morabia A, Menkes MJS, Comstock GW, Tockman MS. Serum retinol and airway obstruction. Am J Epidemiol 1990;132:77–82.
12. Morabia AO, Sorenson A, Kumanyika SK, Abbey H, Cohen BH, Chee E. Vitamin A, cigarette smoking, and airway obstruction. Am Rev Respir Dis 1989;140:1312–1316.
13. Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Shimakawa T, Higgins MW, Sorlie PD, Szklo M. Does dietary vitamin a proect against airway obstruction. Am J Respir Crit Care Med 1994;150:978–982.
14. Rautalahti M, Virtamo J, Haukka J, Heinonen OP, Sundvall J, Albanes D, Huttunen JK. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med 1997;156:1447–1452.
15. Dow L, Tracey M, Villar A, Coggon D, Margetts BM, Campbell MJ, Holgate ST. Does dietary intake of vitamins C and E influence lung function in older people? Am J Respir Crit Care Med 1996;154:1401–1404.
16. Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis SA, Tattersfield, A, Weiss S. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet 1994;344:357–362.
17. Hijazi N, Abalkhail B, Seaton A. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax 2000;55: 775–779.
18. Emelyanov A, Fedoseev G, Barnes PJ. Reduced intracellular magnesium concentrations in asthmatic patients. Eur Respir J 1999;13:38–40.
19. Soutar A, Seaton A, Brown K. Bronchial reactivity and dietary antioxidants. Thorax 1997;52:166–170.
20. Carey IM, Strachan DP, Cook DG. Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med 1998;158:728–733.
21. Butland BK, Fehily AM, Elwood PC. Diet, lung function, and lung function decline in a cohort of 2512 middle aged men. Thorax 2000;55: 102–108.
22. Britton J, Pavord I, Richards K, Knox A, Wisniewski A, Weiss S, Tattersfield A. Dietary sodium intake and the risk of airway hyperreactivity in a random adult population. Thorax 1994;49:875–880.
23. UK General Register Office. Classification of occupations. London: HMSO, 1966.
24. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17–27.
25. Troisi RJ, Willett WC, Weiss ST, Trichopoulos D, Rosner B, Speizer FE. A prospective study of diet and adult-onset asthma. Am J Respir Crit Care Med 1995;151:1401–1408.
26. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531–540.
27. Baker JC, Tunnicliffe WS, Duncanson RC, Ayres JG. Dietary antioxidants and magnesium in type 1 brittle asthma: a case control study. Thorax 1999;54:115–118.
28. Cook DG, Carey IM, Whincup PH, Papacosta O, Chirico S, Bruckdorfer KR, et al. Effect of fresh fruit consumption on lung function and wheeze in children. Thorax 1997;52:628–633.
29. Paiva SAR, Godoy I, Vannucchi H, Favaro RMD, Geraldo RRC, Campana AO. Assessment of vitamin A status in chronic obdstructive pulmonary disease patients and healthy smokers. Am J Clin Nutr 1996;64:928–934.
30. Fogarty A, Lewis S, Weiss S, Britton J. Dietary vitamin E, IgE concentrations, and atopy. Lancet 2000;356:1573–1574.
31. Heinrich J, Holscher B, Bolte G, Winkler G. Allergic sensitization and diet: ecological analysis in selected European cities. Eur Respir J 2001;17:395–402.
Correspondence and requests for reprints should be addressed to Tricia M. McKeever, M.Sc., Division of Respiratory Medicine, Clinical Science Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. E-mail:

Related

No related items
American Journal of Respiratory and Critical Care Medicine
165
9

Click to see any corrections or updates and to confirm this is the authentic version of record